-transparent.png){kind=logo}
Eleven patients with metastatic osteogenic sarcoma were treated with cyclophosphamide, adriamycin, and, in some cases, high-dose methotrexate. In the event of metastatic progression, the dose of cyclophosphamide was escalated by increasing the number of consecutive daily infusions (dose, 45 mg/kg/day). The results indicate that metastatic osteogenic sarcoma is marginally responsive to adriamycin and cyclophosphamide but rarely responsive to high-dose methotrexate as administered in this trial. The response of metastatic lesions was not improved by escalating the dose of cyclophosphamide.
Related Publications
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
February 1978,
Cancer treatment reports,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
December 1977,
Cancer,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
May 1988,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
July 2007,
Current opinion in oncology,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
February 1990,
Cancer,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
January 1985,
Progress in clinical and biological research,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
June 1986,
Clinical orthopaedics and related research,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
April 1981,
National Cancer Institute monograph,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
March 1972,
The American journal of roentgenology, radium therapy, and nuclear medicine,
A S Levine, and
F R Appelbaum, and
R G Graw, and
I T Magrath, and
P A Pizzo, and
D G Poplack, and
J L Ziegler
January 1981,
Cancer treatment reports,
